15250-m-cuypers

102 Chapter 5 REFERENCES 1. Netherlands Cancer Registry. Cijfers over kanker [internet]. Utrecht: Comprehensive Cancer Centre The Netherlands; 2014. http://www.cijfersoverkanker.nl . Accessed 1 October 2014. 2. Post P, Kil P, Crommelin M, Schapers R, Coebergh J-W. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971–1995. Eur J Cancer. 1998;34(5):705-9. 3. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366(11):981-90. 4. Dutch Cancer Society. Kwaliteit van kankerzorg in Nederland: voortgang en blik op de toekomst. Amsterdam: KWF Kankerbestrijding; 2014. 5. National Institute for Public Health and the Environment. Volksgezondheid Toekomst Verkenning In: Nationaal Kompas Volksgezondheid [internet]. Bilthoven: RIVM; 2014. https:// www.volksgezondheidenzorg.info/onderwerp/prostaatkanker. Accessed 1 October 2014. 6. Pickles T, Ruether JD, Weir L, Carlson L, Jakulj F. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int. 2007;100(3):544-51. 7. Van den Bergh RC, Korfage IJ, Bangma CH. Psychological aspects of active surveillance. Curr Opin Urol. 2012;22(3):237-42. 8. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent— update 2013. Eur Urol. 2014;65(1):124-37. 9. Kramer KM, Bennett CL, Pickard AS, Lyonsn EA, Wolf MS, McKoy JM et al. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer. 2005;4(1):15-23. 10. Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L et al. Who makes the decision regarding the treatment of clinically localized prostate cancer–the patient or physician? Cancer. 2013;119(2):421-8. 11. Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer. 2001;84(1):48. 12. Hoffmann TC, Légaré F, Simmons MB, McNamara K, McCaffery K, Trevena LJ et al. Shared decision-making: What do clinicians need to know and why should they bother? Med J Aust. 2014;201(1):35-9. 13. Degner LF, Davison BJ, Sloan JA, Mueller B. Development of a scale to measure information needs in cancer care. J Nurs Meas. 1998;6(2):137-53. 14. Sonn GA, Sadetsky N, Presti JC, Litwin MS. Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol. 2013;189(1):S59-S65. 15. Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol. 2012: 30:1160-77. 16. O'Connor AM, Llewellyn-Thomas HA, Flood AB. Modifying unwarranted variations in health care: shared decision-making using patient decision aids. Health aff. 2004;2004:63-72.